Gurevičienė, Giedrė. 2019. “PD-L1 INHIBITOR PEMBROLIZUMAB – FOR FIRST LINE ADVANCED NON-SMALL CELL LUNG CANCER THERAPY”. Pulmonology and Allergology 3 (2), 177-82. https://doi.org/10.37499/PIA.136.